Leidos Holdings, Inc.
Business
Leidos Holdings, Inc. is a holding company whose principal operating subsidiary provides scientific, engineering and technical services and solutions that deliver digital and mission innovations for government and commercial customers. It offers mission software, cyber operations, digital modernization, integrated systems, rapid prototyping and manufacturing, transportation and health solutions, security detection products, airborne, land, maritime and space systems, and managed health and life sciences services. The company operates four reportable segments: National Security & Digital, Health & Civil, Commercial & International and Defense Systems, with corporate functions presented separately. It serves primarily U.S. federal and defense agencies and also sells products and services to international governments and commercial customers through direct contracts, subcontracting and global deployments.
Summary from filing dated 2025-02-11
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenues | 17,174 | 16,662 | 15,438 | 14,396 | 13,737 | |
| Cost of revenues | 14,075 | 13,864 | 13,194 | 12,312 | 11,723 | |
| Selling, general and administrative expenses | 999 | 983 | 942 | 951 | 851 | |
| Acquisition, integration and restructuring costs | 18 | 16 | 24 | 17 | 27 | |
| Goodwill impairment charges | 0 | 0 | 596 | 0 | 0 | |
| Asset impairment charges | 5 | 11 | 91 | 40 | 4 | |
| Equity earnings of non-consolidated subsidiaries | −32 | −39 | −30 | −12 | −20 | |
| Operating income | 2,109 | 1,827 | 621 | 1,088 | 1,152 | |
| Interest expense, net | −203 | −193 | −212 | −199 | — | |
| Other income (expense), net | 3 | 5 | −6 | −3 | −1 | |
| Income before income taxes | 1,909 | 1,639 | 403 | 886 | 967 | |
| Income tax expense | −447 | −388 | −195 | −193 | −208 | |
| Net income | 1,462 | 1,251 | 208 | 693 | 759 | |
| Less: net income (loss) attributable to non-controlling interest | 14 | −3 | 9 | 8 | 6 | |
| Net income attributable to Leidos common stockholders | 1,448 | 1,254 | 199 | 685 | 753 | |
| Basic (in dollars per share) | 11.31 | 9.36 | 1.45 | 5 | 5.34 | |
| Diluted (in dollars per share) | 11.14 | 9.22 | 1.44 | 4.96 | 5.27 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 1,108 | 849 | 641 | 516 | 727 | |
| Receivables, net | 2,708 | 2,645 | 2,429 | 2,350 | 2,189 | |
| Inventory, net | 342 | 315 | 310 | 287 | 274 | |
| Other current assets | 656 | 525 | 489 | 490 | 429 | |
| Total current assets | 4,814 | 4,334 | 4,005 | 3,643 | 3,619 | |
| Property, plant and equipment, net | 961 | 991 | 961 | 847 | 670 | |
| Intangible assets, net | 458 | 517 | 667 | 952 | 1,177 | |
| Goodwill | 6,342 | 6,084 | 6,112 | 6,696 | 6,744 | |
| Operating lease right-of-use assets, net | 526 | 560 | 512 | 545 | 612 | |
| Deferred tax assets | 48 | 203 | — | — | — | |
| Other long-term assets | 344 | 321 | 438 | 388 | 439 | |
| Total assets | 13,493 | 13,010 | 12,695 | 13,071 | 13,261 | |
| Accounts payable and accrued liabilities | 1,988 | 2,131 | 2,277 | 2,254 | 2,141 | |
| Accrued payroll and employee benefits | 819 | 811 | 695 | 701 | 605 | |
| Current portion of long-term debt | 20 | 618 | 18 | 992 | 483 | |
| Total current liabilities | 2,827 | 3,560 | 2,990 | 3,947 | 3,229 | |
| Long-term debt, net of current portion | 4,628 | 4,052 | 4,664 | 3,928 | 4,593 | |
| Operating lease liabilities | 587 | 621 | 516 | 570 | 589 | |
| Deferred tax liabilities | 221 | 2 | 3 | 40 | 239 | |
| Other long-term liabilities | 268 | 315 | 267 | 233 | 267 | |
| Total liabilities | 8,531 | 8,550 | 8,437 | 8,718 | 8,917 | |
| Commitments and contingencies (Note 21) | — | — | — | — | — | |
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized and no shares issued and outstanding at January 2, 2026 and January 3, 2025 | 0 | 0 | 0 | 0 | 0 | |
| Common stock, $0.0001 par value, 500,000,000 shares authorized, 126,380,657 and 131,163,899 shares issued and outstanding at January 2, 2026, and January 3, 2025, respectively | 0 | 0 | 0 | 0 | 0 | |
| Additional paid-in capital | 319 | 1,112 | 1,885 | 2,005 | 2,423 | |
| Retained earnings | 4,647 | 3,410 | 2,364 | 2,367 | 1,880 | |
| Accumulated other comprehensive loss | −50 | −110 | −48 | −73 | −12 | |
| Total Leidos stockholders equity | 4,916 | 4,412 | 4,201 | 4,299 | 4,291 | |
| Non-controlling interest | 46 | 48 | 57 | 54 | 53 | |
| Total stockholders equity | 4,962 | 4,460 | 4,258 | 4,353 | 4,344 | |
| Total liabilities and stockholders equity | 13,493 | 13,010 | 12,695 | 13,071 | 13,261 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 290 | 290 | 331 | 333 | 325 | |
| Stock-based compensation | 95 | 85 | 77 | 73 | 67 | |
| Deferred income taxes | 369 | −98 | −109 | — | — | |
| Other | 9 | 44 | 28 | 26 | −7 | |
| Receivables | −46 | −220 | −65 | −174 | −5 | |
| Other current assets and other long-term assets | 19 | 96 | 140 | 160 | 143 | |
| Accounts payable and accrued liabilities and other long-term liabilities | −308 | −117 | 53 | −143 | −210 | |
| Accrued payroll and employee benefits | 1 | 121 | −5 | 98 | −32 | |
| Income taxes receivable/payable | −146 | −28 | −158 | 97 | 15 | |
| Net cash provided by operating activities | 1,750 | 1,435 | 1,187 | 992 | 1,033 | |
| Acquisitions of businesses, net of cash acquired | −293 | 0 | −6 | −192 | −622 | |
| Payments for property, equipment and software | −125 | −149 | −207 | −129 | −104 | |
| Proceeds from disposition of businesses | 9 | 0 | 2 | 15 | 0 | |
| Other | 4 | 7 | 0 | −13 | −4 | |
| Net cash used in investing activities | −405 | −142 | −211 | −313 | −730 | |
| Proceeds from debt issuance | 997 | 0 | 1,743 | 380 | 380 | |
| Repayments of borrowings | −1,019 | −18 | −2,045 | −545 | −106 | |
| Payments for debt issuance and modification costs | −7 | 0 | −7 | 0 | 0 | |
| Dividend payments | −211 | −208 | −201 | −199 | −199 | |
| Repurchases of stock and other | −944 | −906 | −246 | −542 | −270 | |
| Proceeds from issuances of stock | 62 | 55 | 50 | 48 | 44 | |
| Net capital distributions to non-controlling interests | −16 | −6 | −9 | −7 | 38 | |
| Other | −7 | −1 | 0 | 0 | 0 | |
| Net cash used in financing activities | −1,145 | −1,084 | −715 | −865 | −113 | |
| Effect of foreign exchange rate changes on cash and cash equivalents | 13 | −10 | 6 | −6 | −2 | |
| Net increase in cash, cash equivalents and restricted cash | 213 | 199 | 267 | −192 | 188 | |
| Cash paid for interest | 220 | 226 | 207 | 195 | 182 | |
| Cash paid for income taxes, net of refunds | 276 | 460 | 435 | 217 | 221 | |
| Property, plant and equipment additions | 5 | 72 | 2 | 7 | 4 | |
| Finance lease obligations | 0 | 0 | 65 | 1 | 51 |